Startseite Objective methods for the assessment of the spinal and supraspinal effects of opioids
Artikel Öffentlich zugänglich

Objective methods for the assessment of the spinal and supraspinal effects of opioids

  • Satu K. Jääskeläinen EMAIL logo
Veröffentlicht/Copyright: 1. Januar 2017
Veröffentlichen auch Sie bei De Gruyter Brill

In this issue of the Scandinavian Journal of Pain, Fischer and coworkers [1] review several methods available for objective measurement of the central nervous system (CNS) effects of opioids and opioid induced analgesia, both at the spinal and the supraspinal levels. This is an important issue as objective, quantifiable markers for opioid analgesia would be of utmost importance both in basic research and drug development, as well as in the assessment of therapeutic efficacy and drug resistant pain conditions in the clinic. Nevertheless, clinical trials mostly rely on subjective reports on the pain estimated with visual analogue scale (VAS) or numerical rating scale (NRS). The task to reduce the subjective, multidimensional experience of pain to objective biomarkers is challenging. This review [1] ambitiously tackles the problem showing many potential tools already available for the assessment of central nervous system effects of opioids and their relationship to analgesia but, simultaneously, it highlights the problems and open questions in the field.

1 The methods available for objective assessment of opioid effects

Pupillometry seems to be a reliable and feasible measure to assess central opioid effects even on the chair-side as the authors have previously shown [2]. However, as the pupillary size is controlled by many external (e.g. ambience light) and internal factors (e.g. anxiety) via the autonomous system that can also be affected by peripheral neuropathy or central nervous system lesions, its clinical use may be complicated. In addition, usefulness of pupillometry in patients on chronic opioid therapy should be evaluated in future clinical studies as most of the current data comes from experimental studies on acute opioid administration in healthy subjects or recreational opioid users [1].

2 More direct assessment of the CNS effects of opioids

Functional brain imaging with pharmaco-fMRI or neurotransmitter PET scans offer reliable precision-tools, but require expensive equipment, qualified personnel, and time. Thus, they may be more suitable for scientific studies than for clinical work.

3 Neurophysiological methods

Nociceptive flexion reflex (RIII), electroencephalography (EEG), and somatosensory (SEP) or pain evoked potentials (LEP, CHEP) might provide less expensive and more feasible means to analyze opioid effects. They also allow dissecting the spinal and supraspinal components, and simultaneously control the non-specific sedative effects of opioids. However, because of controversial or preliminary results, these techniques still require both basic and clinical research before their usefulness can be determined. Furthermore, unidimensional image with one single biomarker may not reflect the actual patient experience precisely enough.

4 Future research

Clinical research as well as standardization and validation of the objective markers described [1] are needed before the methods can reliably be applied to assess efficacy of opioid analgesia at individual patient level. The markers should be evaluated not only in healthy subjects and acute pain but also especially in chronic pain patients on different opioidergic treatments. Moreover, the specificity of these markers for analgesia should be addressed as sedation and emotional state may influence the results. Furthermore, the causes for between-subjects variability in the efficacy of opioid analgesia, and the genetic determinants of this variation [3] should also be taken into account in the validation process. This review gives a good starting point for many future trials.


DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2016.10.001.



Department of Clinical Neurophysiology, University of Turku and Turku University Hospital, Postal Box 52, 20521 Turku, Finland. Fax: +35823133922.

  1. Conflict of interest: None declared.

References

[1] Fischer IW, Hansen TM, Lelic D, Brokjær A, Frøkjær JB, Christrup LL, Olesen AE. Objective methods for the assessment of the spinal and supraspinal effects of opioids. Scand J Pain 2017;14:15–24.Suche in Google Scholar

[2] Brokjær A, Olesen AE, Kreilgaard M, GraversenC, Gram M, Christrup LL, Dahan A, Drewes AM. Objective markers of the analgesic response to morphine in experimental pain research. J Pharmacol Toxicol Methods 2015;73: 7–14.Suche in Google Scholar

[3] Nishizawa D, Hayashida M, Nagashima M, Koga H, Ikeda K. Genetic polymorphisms and human sensitivity to opioid analgesics. Methods Mol Biol 2010;617:395–420.Suche in Google Scholar

Published Online: 2017-01-01
Published in Print: 2017-01-01

© 2016 Scandinavian Association for the Study of Pain

Artikel in diesem Heft

  1. Scandinavian Journal of Pain
  2. Editorial comment
  3. Patients with chronic neck-pain after trauma do not differ in type of symptoms and signs, but suffer more than patients with chronic neck pain without a traumatic onset
  4. Observational study
  5. Chronic neck pain patients with traumatic or non-traumatic onset: Differences in characteristics. A cross-sectional study
  6. Editorial Comment
  7. Re-enforcing therapeutic effect by positive expectations of pain-relief from our interventions
  8. Original experimental
  9. Effect of expectation on pain assessment of lower- and higher-intensity stimuli
  10. Editorial comment
  11. Objective methods for the assessment of the spinal and supraspinal effects of opioids
  12. Topical review
  13. Objective methods for the assessment of the spinal and supraspinal effects of opioids
  14. Editorial Comment
  15. Multi-target treatment of bone cancer pain using synergistic combinations of pharmacological compounds in experimental animals
  16. Original experimental
  17. Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain
  18. Editorial comment
  19. Terminal cancer pain intractable by conventional pain management can be effectively relieved by intrathecal administration of a local anaesthetic plus an opioid and an alfa2-agonist into the cerebro-spinal-fluid
  20. Observational study
  21. Multimodal intrathecal analgesia in refractory cancer pain
  22. Editorial comment
  23. Treatment success in neck pain: The added predictive value of psychosocial variables in addition to clinical variables
  24. Observational study
  25. Treatment success in neck pain: The added predictive value of psychosocial variables in addition to clinical variables
  26. Editorial comment
  27. Why are some patients with chronic pain from anterior abdominal nerve entrapment syndrome (ACNES) refractory to peripheral treatment with neurectomy?
  28. Clinical pain research
  29. Treatment response and central pain processing in Anterior Cutaneous Nerve Entrapment Syndrome: An explorative study
  30. Editorial comment
  31. Gain in functions before pain reduction during intensive multidisciplinary paediatric pain rehabilitation programme
  32. Clinical pain research
  33. Physical and occupational therapy outcomes: Adolescents’ change in functional abilities using objective measures and self-report
  34. Editorial comment
  35. Complex Regional Pain Syndrome (CRPS): High risk of CRPS after trauma in another limb in patients who already have CRPS in one hand or foot: Lasting changes in neural pain modulating systems?
  36. Clinical pain research
  37. The risk of pain syndrome affecting a previously non-painful limb following trauma or surgery in patients with a history of complex regional pain syndrome
  38. Editorial Comment
  39. Positive affect could reduce the impact of pain
  40. Original experimental
  41. The buffering role of positive affect on the association between pain intensity and pain related outcomes
  42. Editorial comment
  43. The meaning and consequences of amputation and mastectomy from the perspective of pain and suffering – Lessons to be learned and relearned
  44. Clinical pain research
  45. The meaning and consequences of amputation and mastectomy from the perspective of pain and suffering
  46. Editorial comment
  47. Invasive intervention for “intractable” Complex Regional Pain Syndromes (CRPS)?
  48. Educational case report
  49. Intrathecal management of complex regional pain syndrome: A case report and literature
  50. Observational study
  51. Item response theory analysis of the Pain Self-Efficacy Questionnaire
  52. Announcement
  53. Scandinavian Association for the Study of Pain (SASP): Annual Meeting 2017
Heruntergeladen am 17.11.2025 von https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2016.11.012/html
Button zum nach oben scrollen